International safety notice

URGENT - Field Safety Notice - Use of auto servo ventilation (ASV) devices on patients with symptomatic chronic heart failure (NYHA 2-4) and reduced LVEF≤45%, AND moderate to severe predominant central sleep apnea, Philips

Germany / BfArM · DEU · May 26, 2015

Key facts

Title URGENT - Field Safety Notice - Use of auto servo ventilation (ASV) devices on patients with symptomatic chronic heart failure (NYHA 2-4) and reduced LVEF≤45%, AND moderate to severe predominant central sleep apnea, Philips
Regulator Germany / BfArM
Country DEU
Brand URGENT - Field Safety Notice - Use of auto servo ventilation (ASV) devices on patients with symptomatic chronic heart failure (NYHA 2-4) and reduced LVEF≤45%, AND moderate to severe predominant central sleep apnea, Philips
Manufacturer URGENT - Field Safety Notice - Use of auto servo ventilation (ASV) devices on patients with symptomatic chronic heart failure (NYHA 2-4) and reduced LVEF≤45%, AND moderate to severe predominant central sleep apnea, Philips
Models LVEF≤45, HR=1.335, 1.666, 387‐3311, 1.070, 0.010
Date May 26, 2015
Regulator page bfarm.de

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices